{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T21:11:32Z","timestamp":1716325892953},"reference-count":104,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,4,22]],"date-time":"2019-04-22T00:00:00Z","timestamp":1555891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,4,22]],"date-time":"2019-04-22T00:00:00Z","timestamp":1555891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s11886-019-1134-8","type":"journal-article","created":{"date-parts":[[2019,4,22]],"date-time":"2019-04-22T07:02:35Z","timestamp":1555916555000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Refractory Angina: the Current State of Mechanical Therapies"],"prefix":"10.1007","volume":"21","author":[{"given":"Amod","family":"Amritphale","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nupur","family":"Amritphale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,4,22]]},"reference":[{"issue":"5","key":"1134_CR1","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1053\/euhj.2001.2706","volume":"23","author":"C Mannheimer","year":"2002","unstructured":"Mannheimer C, Camici P, Chester MR, et al. The problem of chronic refractory angina. Report from the ESC Joint Study Group on the treatment of refractory angina. Eur Heart J. 2002;23(5):355\u201370.","journal-title":"Eur Heart J"},{"key":"1134_CR2","doi-asserted-by":"crossref","unstructured":"Povsic TJ, Broderick S, Anstrom KJ, et al. Predictors of longterm clinical endpoints in patients with refractory angina. J Am Heart Assoc. 2015; vol. 4, no. 2, article e001287.","DOI":"10.1161\/JAHA.114.001287"},{"issue":"2, Supplement","key":"1134_CR3","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1016\/j.cjca.2011.07.007","volume":"28","author":"M McGillion","year":"2012","unstructured":"McGillion M, Arthur HM, Cook A, et al. Management of patients with refractory angina: Canadian Cardiovascular Society\/Canadian Pain Society Joint Guidelines. Can J Cardiol. 2012;28(2, Supplement):S20\u201341.","journal-title":"Can J Cardiol"},{"key":"1134_CR4","doi-asserted-by":"crossref","unstructured":"Mukherjee et al. Eur Heart J. 2013; Volume 34, Issue 34, Pages 2655\u20132657.","DOI":"10.1093\/eurheartj\/eht190"},{"key":"1134_CR5","doi-asserted-by":"crossref","unstructured":"\u2022 Bassetti B, Nigro P, Catto V, et al. Cell therapy for refractory angina: a reappraisal. Stem Cells Int. 2017;2017:5648690. Excellent overview of the key elements, options, and efficacies of cell-based therapies for refractory angina.","DOI":"10.1155\/2017\/5648690"},{"key":"1134_CR6","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1161\/CIRCULATIONAHA.109.923482","volume":"122","author":"RW Braith","year":"2010","unstructured":"Braith RW, Conti CR, Nichols WW, Choi CY, Khuddus MA, Beck DT, et al. Enhanced external counterpulsation improves peripheral artery flow-mediated dilation in patients with chronic angina: a randomized sham-controlled study. Circulation. 2010;122:1612\u201320.","journal-title":"Circulation"},{"key":"1134_CR7","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0735-1097(00)01095-0","volume":"37","author":"H Urano","year":"2001","unstructured":"Urano H, Ikeda H, Ueno T, Matsumoto T, Murohara T, Imaizumi T. Enhanced external counterpulsation improves exercise tolerance, reduces exercise-induced myocardial ischemia and improves left ventricular diastolic filling in patients with coronary artery disease. J Am Coll Cardiol. 2001;37:93\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"1134_CR8","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/S0002-9149(02)02191-4","volume":"89","author":"TP Stys","year":"2002","unstructured":"Stys TP, Lawson WE, Hui JC, et al. Effects of enhanced external counterpulsation on stress radionuclide coronary perfusion and exercise capacity in chronic stable angina pectoris. Am J Cardiol. 2002;89:822\u20134.","journal-title":"Am J Cardiol"},{"key":"1134_CR9","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1016\/j.jacc.2003.05.013","volume":"42","author":"M Shechter","year":"2003","unstructured":"Shechter M, Matetzky S, Feinberg MS, Chouraqui P, Rotstein Z, Hod H. External counterpulsation therapy improves endothelial function in patients with refractory angina pectoris. J Am Coll Cardiol. 2003;42:2090\u20135.","journal-title":"J Am Coll Cardiol"},{"key":"1134_CR10","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.amjcard.2006.01.053","volume":"98","author":"M Akhtar","year":"2006","unstructured":"Akhtar M, Wu GF, Du ZM, et al. Effect of external counterpulsation on plasma nitric oxide and endothelin-1 levels. Am J Cardiol. 2006;98:28\u201330.","journal-title":"Am J Cardiol"},{"key":"1134_CR11","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/j.jacc.2006.04.094","volume":"48","author":"WW Nichols","year":"2006","unstructured":"Nichols WW, Estrada JC, Braith RW, Owens K, Conti CR. Enhanced external counterpulsation treatment improves arterial wall properties and wave reflection characteristics in patients with refractory angina. J Am Coll Cardiol. 2006;48:1208\u201314.","journal-title":"J Am Coll Cardiol"},{"key":"1134_CR12","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1016\/S0735-1097(99)00140-0","volume":"33","author":"RR Arora","year":"1999","unstructured":"Arora RR, Chou TM, Jain D, Fleishman B, Crawford L, McKiernan T, et al. The multicenter study of enhanced external counterpulsation (MUST-EECP): effect of EECP on exercise-induced myocardial ischemia and anginal episodes. J Am Coll Cardiol. 1999;33:1833\u201340.","journal-title":"J Am Coll Cardiol"},{"key":"1134_CR13","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1016\/j.jacc.2014.07.017","volume":"64","author":"SD Fihn","year":"2014","unstructured":"Fihn SD, Blankenship JC, Alexander KP, et al. 2014 ACC\/AHA\/AATS\/PCNA\/SCAI\/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2014;64:1929.","journal-title":"J Am Coll Cardiol"},{"key":"1134_CR14","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1016\/j.amjcard.2011.01.021","volume":"107","author":"DP Casey","year":"2011","unstructured":"Casey DP, Beck DT, Nichols WW, Conti CR, Choi CY, Khuddus MA, et al. Effects of enhanced external counterpulsation on arterial stiffness and myocardial oxygen demand in patients with chronic angina pectoris. Am J Cardiol. 2011;107:1466\u201372.","journal-title":"Am J Cardiol"},{"key":"1134_CR15","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1016\/S0735-1097(03)00329-2","volume":"41","author":"PO Bonetti","year":"2003","unstructured":"Bonetti PO, Barsness GW, Keelan PC, Schnell TI, Pumper GM, Kuvin JT, et al. Enhanced external counterpulsation improves endothelial function in patients with symptomatic CAD. J Am Coll Cardiol. 2003;41:1761\u201381.","journal-title":"J Am Coll Cardiol"},{"key":"1134_CR16","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1159\/000111925","volume":"110","author":"A Barsheshet","year":"2008","unstructured":"Barsheshet A, Hod H, Shechter M, Sharabani-Yosef O, Rosenthal E, Barbash IM, et al. The effects of external counter pulsation therapy on circulating endothelial progenitor cells in patients with angina pectoris. Cardiology. 2008;110:160\u20136.","journal-title":"Cardiology"},{"key":"1134_CR17","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.amjcard.2007.08.031","volume":"101","author":"DP Casey","year":"2008","unstructured":"Casey DP, Conti CR, Nichols WW, Choi CY, Khuddus MA, Braith RW. Effect of enhanced external counterpulsation on inflammatory cytokines and adhesion molecules in patients with angina pectoris and angiographic CAD. Am J Cardiol. 2008;101:300\u20132.","journal-title":"Am J Cardiol"},{"key":"1134_CR18","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1126\/science.150.3699.971","volume":"150","author":"R Melzack","year":"1965","unstructured":"Melzack R, Wall PD. Pain mechanisms: a new theory. Science. 1965;150:971\u20139.","journal-title":"Science"},{"key":"1134_CR19","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/0304-3959(87)90070-4","volume":"28","author":"DF Murphy","year":"1987","unstructured":"Murphy DF, Giles KE. Dorsal column stimulation for pain relief from intractable angina pectoris. Pain. 1987;28:365\u20138.","journal-title":"Pain"},{"key":"1134_CR20","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/S0008-6363(00)00095-X","volume":"47","author":"RD Foreman","year":"2000","unstructured":"Foreman RD, Linderoth B, Ardell JL, Barron KW, Chandler MJ, Hull SS Jr, et al. Modulation of intrinsic cardiac neurons by spinal cord stimulation: implications for its therapeutic use in angina pectoris. Cardiovasc Res. 2000;47:367\u201375.","journal-title":"Cardiovasc Res"},{"key":"1134_CR21","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1136\/heart.83.2.217","volume":"83","author":"S Murray","year":"2000","unstructured":"Murray S, Collins PD, James MA. Neurostimulation treatment for angina pectoris. Heart. 2000;83:217\u201320.","journal-title":"Heart"},{"key":"1134_CR22","first-page":"82","volume":"82","author":"IA TenVaarwerk","year":"1999","unstructured":"TenVaarwerk IA, Jessurun GA, DeJongste MJ, et al. Clinical outcome of patients treated with spinal cord stimulation for therapeutically refractory angina pectoris. The Working Group on Neurocardiology Heart. 1999;82:82.","journal-title":"The Working Group on Neurocardiology Heart"},{"key":"1134_CR23","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1136\/hrt.82.1.89","volume":"82","author":"S Murray","year":"1999","unstructured":"Murray S, Carson KG, Ewings PD, et al. Spinal cord stimulation significantly decreases the need for acute hospital admission for chest pain in patients with refractory angina pectoris. Heart. 1999;82:89\u201392.","journal-title":"Heart"},{"key":"1134_CR24","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1111\/j.1540-8159.1999.tb00346.x","volume":"22","author":"GA Jessurun","year":"1999","unstructured":"Jessurun GA, DeJongste MJ, Hautvast RW, et al. Clinical follow-up after cessation of chronic electrical neuromodulation in patients with severe coronary artery disease: a prospective randomized controlled study on putative involvement of sympathetic activity. Pacing Clin Electrophysiol. 1999;22:1432\u20139.","journal-title":"Pacing Clin Electrophysiol"},{"key":"1134_CR25","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1161\/01.CIR.97.12.1157","volume":"97","author":"C Mannheimer","year":"1998","unstructured":"Mannheimer C, Eliasson T, Augustinsson LE, Blomstrand C, Emanuelsson H, Larsson S, et al. Electrical stimulation versus coronary artery bypass surgery in severe angina pectoris: the ESBY study. Circulation. 1998;97:1157\u201363.","journal-title":"Circulation"},{"key":"1134_CR26","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1159\/000007040","volume":"94","author":"H Norrsell","year":"2000","unstructured":"Norrsell H, Pilhall M, Eliasson T, Mannheimer C. Effects of spinal cord stimulation and coronary artery bypass grafting on myocardial ischemia and heart rate variability: further results from the ESBY study. Cardiology. 2000;94:12\u20138.","journal-title":"Cardiology"},{"key":"1134_CR27","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1093\/eurheartj\/ehi827","volume":"27","author":"D McNab","year":"2006","unstructured":"McNab D, Khan SN, Sharples LD, Ryan JY, Freeman C, Caine N, et al. An open label, single-centre, randomized trial of spinal cord stimulation vs. percutaneous myocardial laser revascularization in patients with refractory angina pectoris: the SPiRiT trial. Eur Heart J. 2006;27:1048\u201353.","journal-title":"Eur Heart J"},{"key":"1134_CR28","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1016\/j.jacc.2005.06.079","volume":"46","author":"MB Leon","year":"2005","unstructured":"Leon MB, Kornowski R, Downey WE, Weisz G, Baim DS, Bonow RO, et al. A blinded, randomized, placebo-controlled trial of percutaneous laser myocardial revascularization to improve angina symptoms in patients with severe coronary disease. J Am Coll Cardiol. 2005;46:1812\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"1134_CR29","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1093\/eurheartj\/ehi089","volume":"26","author":"GA Lanza","year":"2005","unstructured":"Lanza GA, Sestito A, Sgueglia GA, Infusino F, Papacci F, Visocchi M, et al. Effect of spinal cord stimulation on spontaneous and stress-induced angina and \u2018ischemialike\u2019 ST-segment depression in patients with cardiac syndrome X. Eur Heart J. 2005;26:983\u20139.","journal-title":"Eur Heart J"},{"key":"1134_CR30","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0022-5223(19)33205-2","volume":"50","author":"PK Sen","year":"1965","unstructured":"Sen PK, Udwadia TE, Kinare SG, Parulkar GB. Transmyocardial acupuncture: a new approach to myocardial revascularization. J Thorac Cardiovasc Surg. 1965;50:181\u20139.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1134_CR31","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/lsm.1900020209","volume":"2","author":"M Mirhoseini","year":"1982","unstructured":"Mirhoseini M, Muckerheide M, Cayton MM. Transventricular revascularization by laser. Lasers Surg Med. 1982;2:187\u201398.","journal-title":"Lasers Surg Med"},{"key":"1134_CR32","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/lsm.1900060507","volume":"6","author":"M Mirhoseini","year":"1986","unstructured":"Mirhoseini M, Cayton MM, Shelgikar S, Fisher JC. Laser myocardial revascularization. Lasers Surg Med. 1986;6:459\u201361.","journal-title":"Lasers Surg Med"},{"issue":"Suppl II","key":"1134_CR33","doi-asserted-by":"publisher","first-page":"II-58","DOI":"10.1161\/01.CIR.92.9.58","volume":"92","author":"OH Frazier","year":"1995","unstructured":"Frazier OH, Cooley DA, Kadipasaoglu KA, et al. Myocardial revascularization with laser: preliminary findings. Circulation. 1995;92(Suppl II):II-58\u201365.","journal-title":"Circulation"},{"key":"1134_CR34","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/S0022-5223(96)70381-1","volume":"111","author":"KA Horvath","year":"1996","unstructured":"Horvath KA, Mannting F, Cummings N, Shernan SK, Cohn LH. Transmyocardial laser revascularization: operative techniques and clinical results at two years. J Thorac Cardiovasc Surg. 1996;111:1047\u201353.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1134_CR35","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/S0022-5223(97)70221-6","volume":"113","author":"KA Horvath","year":"1997","unstructured":"Horvath KA, Cohn LH, Cooley DA, Crew JR, Frazier OH, Griffith BP, et al. Transmyocardial laser revascularization: results of a multicenter trial with transmyocardial laser revascularization used as sole therapy for end-stage coronary artery disease. Thorac Cardiovasc Surg. 1997;113:645\u201354.","journal-title":"Thorac Cardiovasc Surg"},{"key":"1134_CR36","first-page":"220","volume":"21","author":"DA Cooley","year":"1994","unstructured":"Cooley DA, Frazier OH, Kadipasaoglu KA, Pehlivanoglu S, Shannon RL, Angelini P. Transmyocardial laser revascularization: anatomic evidence of long-term channel patency. Tex Heart Inst J. 1994;21:220\u20134.","journal-title":"Tex Heart Inst J"},{"key":"1134_CR37","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/S0022-5223(96)70339-2","volume":"111","author":"DA Cooley","year":"1996","unstructured":"Cooley DA, Frazier OH, Kadipasaoglu KA, Lindenmeir MH, Pehlivanoglu S, Kolff JW, et al. Transmyocardial laser revascularization: clinical experience with twelve-month follow-up. J Thorac Cardiovasc Surg. 1996;111:791\u20139.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1134_CR38","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/S1010-7940(97)01203-7","volume":"11","author":"JG Vincent","year":"1997","unstructured":"Vincent JG, Bardos P, Kruse J, Maass D. End stage coronary artery disease treated with the transmyocardial CO2 laser revascularization: a chance for the \u2018inoperable\u2019 patient. Eur J Cardiothorac Surg. 1997;11:888\u201394.","journal-title":"Eur J Cardiothorac Surg"},{"key":"1134_CR39","unstructured":"March RJ, Boyce S, Cooley DA, et al. Improved event survival following transmyocardial laser revascularization versus medical management in patient with unreconstructed coronary artery disease. In: Program and abstracts of the 77th Annual Meeting of the American Association of Thoracic Surgery, Washington, D.C., May 4\u20137, 1997; 94. abstract."},{"issue":"Suppl 1","key":"1134_CR40","doi-asserted-by":"publisher","first-page":"S100","DOI":"10.1016\/S1010-7940(98)00114-6","volume":"14","author":"KB Allen","year":"1998","unstructured":"Allen KB, Dowling RD, Heimansohn DA, Reitsma E, Didelot L, Shaar CJ. Transmyocardial revascularization utilizing a holmium:YAG laser. Eur J Cardiothorac Surg. 1998;14(Suppl 1):S100\u20134.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"Suppl II","key":"1134_CR41","first-page":"II-73","volume":"98","author":"RD Dowling","year":"1998","unstructured":"Dowling RD, Petracek MR, Selinger SL, Allen KB. Transmyocardial revascularization in patients with refractory, unstable angina. Circulation. 1998;98(Suppl II):II-73\u20136.","journal-title":"Circulation"},{"issue":"Suppl I","key":"1134_CR42","first-page":"I","volume":"98","author":"KB Allen","year":"1998","unstructured":"Allen KB, Fudge FL, Schoettle GP Jr, Selinger SL, Shaar CJ, Dowling RD. Prospective randomized multi-center trial of transmyocardial revascularization versus maximal medical management in patients with refractory class IV angina: 12-month results. Circulation. 1998;98(Suppl I):I\u2013476 abstract.","journal-title":"Circulation"},{"key":"1134_CR43","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/0003-4975(95)01134-X","volume":"61","author":"T Kohmoto","year":"1996","unstructured":"Kohmoto T, Fisher PE, Gu A, Zhu SM, Yano OJ, Spotnitz HM, et al. Does blood flow through holmium:YAGtransmyocardial laser channels? Ann Thorac Surg. 1996;61:861\u20138.","journal-title":"Ann Thorac Surg"},{"key":"1134_CR44","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/S0003-4975(97)00102-1","volume":"63","author":"T Kohmoto","year":"1997","unstructured":"Kohmoto T, Fisher PE, Gu A, Zhu SM, DeRosa CM, Smith CR, et al. Physiology, histology, and 2-week morphology of acute transmyocardial channels made with a CO2 laser. Ann Thorac Surg. 1997;63:1275\u201383.","journal-title":"Ann Thorac Surg"},{"key":"1134_CR45","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1016\/0003-4975(96)00090-2","volume":"61","author":"D Burkhoff","year":"1996","unstructured":"Burkhoff D, Fisher PE, Apfelbaum M, Kohmoto T, DeRosa CM, Smith CR. Histologic appearance of transmyocardial laser channels after 4 1\/2 weeks. Ann Thorac Surg. 1996;61:1532\u20135.","journal-title":"Ann Thorac Surg"},{"key":"1134_CR46","doi-asserted-by":"publisher","first-page":"II134","DOI":"10.1161\/circ.100.suppl_2.Ii-134","volume":"100","author":"O Rimoldi","year":"1999","unstructured":"Rimoldi O, Burns SM, Rosen SD, et al. Measurement of myocardial blood flow with positron emission tomography before and after transmyocardial laser revascularization. Circulation. 1999;100:II134.","journal-title":"Circulation"},{"key":"1134_CR47","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1056\/NEJM199909303411402","volume":"341","author":"OH Frazier","year":"1999","unstructured":"Frazier OH, March RJ, Horvath KA. Transmyocardial revascularization with a carbon dioxide laser in patients with end-stage coronary artery disease. N Engl J Med. 1999;341:1021\u20138.","journal-title":"N Engl J Med"},{"key":"1134_CR48","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1056\/NEJM199909303411403","volume":"341","author":"KB Allen","year":"1999","unstructured":"Allen KB, Dowling RD, Fudge TL, Schoettle GP, Selinger SL, Gangahar DM, et al. Comparison of transmyocardial revascularization with medical therapy in patients with refractory angina. N Engl J Med. 1999;341:1029\u201336.","journal-title":"N Engl J Med"},{"key":"1134_CR49","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/S0140-6736(99)08113-1","volume":"354","author":"D Burkhoff","year":"1999","unstructured":"Burkhoff D, Schmidt S, Schulman SP, et al. Transmyocardial laser revascularisation compared with continued medical therapy for treatment of refractory angina pectoris: a prospective randomised trial. ATLANTIC Investigators Angina Treatments-Lasers and Normal Therapies in Comparison. Lancet. 1999;354:885.","journal-title":"Lancet"},{"key":"1134_CR50","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/S1010-7940(98)00033-5","volume":"13","author":"A Diegeler","year":"1998","unstructured":"Diegeler A, Schneider J, Lauer B, Mohr FW, Kluge R. Transmyocardial laser revascularization using the Holium-YAG laser for treatment of end stage coronary artery disease. Eur J Cardiothorac Surg. 1998;13:392\u20137.","journal-title":"Eur J Cardiothorac Surg"},{"key":"1134_CR51","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1053\/euhj.1998.1202","volume":"20","author":"SM Burns","year":"1999","unstructured":"Burns SM, Sharples LD, Tait S, et al. The transmyocardial laser revascularization international registry report. Eur Heart J. 1999;20:31\u20137.","journal-title":"Eur Heart J"},{"key":"1134_CR52","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/S1043-0679(99)70013-4","volume":"11","author":"RJ March","year":"1999","unstructured":"March RJ. Transmyocardial laser revascularization with the CO2 laser: one year results of a randomized, controlled trial. Semin Thorac Cardiovasc Surg. 1999;11:12.","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"1134_CR53","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1016\/S0735-1097(02)01828-4","volume":"39","author":"L Aaberge","year":"2002","unstructured":"Aaberge L, Rootwelt K, Blomhoff S, Saatvedt K, Abdelnoor M, Forfang K. Continued symptomatic improvement three to five years after transmyocardial revascularization with CO(2) laser: a late clinical follow-up of the Norwegian randomized trial with transmyocardial revascularization. J Am Coll Cardiol. 2002;39:1588\u201393.","journal-title":"J Am Coll Cardiol"},{"key":"1134_CR54","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1016\/j.athoracsur.2004.01.008","volume":"77","author":"KB Allen","year":"2004","unstructured":"Allen KB, Dowling RD, Angell WW, Gangahar DM, Fudge TL, Richenbacher W, et al. Transmyocardial revascularization: 5-year follow-up of a prospective, randomized multicenter trial. Ann Thorac Surg. 2004;77:1228\u201334.","journal-title":"Ann Thorac Surg"},{"key":"1134_CR55","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S0140-6736(98)11478-2","volume":"353","author":"PM Schofield","year":"1999","unstructured":"Schofield PM, Sharples LD, Caine N, Burns S, Tait S, Wistow T, et al. Transmyocardial laser revascularisation in patients with refractory angina: a randomised controlled trial. Lancet. 1999;353:519\u201324.","journal-title":"Lancet"},{"key":"1134_CR56","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1053\/euhj.1998.1152","volume":"19","author":"H N\u00e4gele","year":"1998","unstructured":"N\u00e4gele H, Stubbe HM, Nienaber C, R\u00f6diger W. Results of transmyocardial laser revascularization in non-revascularizable coronary artery disease after 3 years follow-up [ssee comments]. Eur Heart J. 1998;19:1525\u201330.","journal-title":"Eur Heart J"},{"key":"1134_CR57","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/S0003-4975(99)01573-8","volume":"69","author":"O Tjomsland","year":"2000","unstructured":"Tjomsland O, Aaberge L, Almdahl SM, Dragsund M, Moelstad P, Saatvedt K, et al. Perioperative cardiac function and predictors for adverse events after transmyocardial laser treatment. Ann Thorac Surg. 2000;69:1098\u2013103.","journal-title":"Ann Thorac Surg"},{"key":"1134_CR58","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1016\/S0735-1097(00)00519-2","volume":"35","author":"L Aaberge","year":"2000","unstructured":"Aaberge L, Nordstrand K, Dragsund M, et al. Transmyocardial revascularization with CO2 laser in patients with refractory angina pectoris. Clinical results from the Norwegian randomized trial. J Am Coll Cardiol. 2000;35:1170.","journal-title":"J Am Coll Cardiol"},{"key":"1134_CR59","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0735-1097(99)00162-X","volume":"34","author":"D Burkhoff","year":"1999","unstructured":"Burkhoff D, Wesley MN, Resar JR, Lansing AM. Factors correlating with risk of mortality after transmyocardial revascularization. J Am Coll Cardiol. 1999;34:55\u201361.","journal-title":"J Am Coll Cardiol"},{"key":"1134_CR60","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/S0735-1097(99)00645-2","volume":"35","author":"GC Hughes","year":"2000","unstructured":"Hughes GC, Shah AS, Yin B, Shu M, Donovan CL, Glower DD, et al. Early postoperative changes in regional systolic and diastolic left ventricular function after transmyocardial laser revascularization: a comparison of holmium:YAG and CO2 lasers. J Am Coll Cardiol. 2000;35:1022\u201330.","journal-title":"J Am Coll Cardiol"},{"key":"1134_CR61","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/S0003-4975(99)00972-8","volume":"68","author":"BG Hattler","year":"1999","unstructured":"Hattler BG, Griffith BP, Zenati MA, Crew JR, Mirhoseini M, Cohn LH, et al. Transmyocardial laser revascularization in the patient with unmanageable unstable angina. Ann Thorac Surg. 1999;68:1203\u20139.","journal-title":"Ann Thorac Surg"},{"key":"1134_CR62","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/S0022-5223(00)70134-6","volume":"119","author":"KB Allen","year":"2000","unstructured":"Allen KB, Dowling RD, DelRossi AJ, et al. Transmyocardial laser revascularization combined with coronary artery bypass grafting: a multicenter, blinded, prospective, randomized, controlled trial. J Thorac Cardiovasc Surg. 2000;119:540\u20139.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1134_CR63","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.athoracsur.2004.04.049","volume":"78","author":"KB Allen","year":"2004","unstructured":"Allen KB, Dowling RD, Schuch DR, Pfeffer TA, Marra S, Lefrak EA, et al. Adjunctive transmyocardial revascularization: five-year follow-up of a prospective, randomized trial. Ann Thorac Surg. 2004;78:458\u201365.","journal-title":"Ann Thorac Surg"},{"key":"1134_CR64","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1089\/clm.1997.15.293","volume":"15","author":"CB Kim","year":"1997","unstructured":"Kim CB, Oesterle SN. Percutaneous transmyocardial revascularization. J Clin Laser Med Surg. 1997;15:293\u20138.","journal-title":"J Clin Laser Med Surg"},{"key":"1134_CR65","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1097\/00019501-199809080-00010","volume":"9","author":"R Kornowski","year":"1998","unstructured":"Kornowski R, Hong MK, Haudenschild CC, Leon MB. Feasibility and safety of percutaneous laser revascularization using the biosense system in porcine hearts. Coron Artery Dis. 1998;9:535\u201340.","journal-title":"Coron Artery Dis"},{"key":"1134_CR66","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1016\/S0735-1097(99)00419-2","volume":"34","author":"B Lauer","year":"1999","unstructured":"Lauer B, Junghans U, Stahl F, Kluge R, Oesterle SN, Schuler G. Catheter-based percutaneous myocardial laser revascularization in patients with end-stage coronary artery disease. J Am Coll Cardiol. 1999;34:1663\u201370.","journal-title":"J Am Coll Cardiol"},{"key":"1134_CR67","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/S0002-9149(98)00902-3","volume":"83","author":"FA Shawl","year":"1999","unstructured":"Shawl FA, Domanski MJ, Kaul U, Dougherty KG, Hoff S, Rigali GE, et al. Procedural results and early clinical outcome of percutaneous transluminal myocardial revascularization. Am J Cardiol. 1999;83:498\u2013501.","journal-title":"Am J Cardiol"},{"key":"1134_CR68","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1016\/S0140-6736(00)03203-7","volume":"356","author":"SN Oesterle","year":"2000","unstructured":"Oesterle SN, Sanborn TA, Ali N, et al. Percutaneous transmyocardial laser revascularisation for severe angina: the PACIFIC randomised trial. Potential Class Improvement From Intramyocardial Channels. Lancet. 2000;356:1705.","journal-title":"Lancet"},{"key":"1134_CR69","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1016\/S0735-1097(02)01829-6","volume":"39","author":"GW Stone","year":"2002","unstructured":"Stone GW, Teirstein PS, Rubenstein R, Schmidt D, Whitlow PL, Kosinski EJ, et al. A prospective, multicenter, randomized trial of percutaneous transmyocardial laser revascularization in patients with nonrecanalizable chronic total occlusions. J Am Coll Cardiol. 2002;39:1581\u20137.","journal-title":"J Am Coll Cardiol"},{"key":"1134_CR70","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1097\/00000542-199011000-00008","volume":"73","author":"S Blomberg","year":"1990","unstructured":"Blomberg S, Emanuelsson H, Kvist H, Lamm C, Ponten J, Waagstein F, et al. Effects of thoracic epidural anesthesia on coronary arteriesand arterioles in patients with coronary artery disease. Anesthesiology. 1990;73:840\u20137.","journal-title":"Anesthesiology"},{"key":"1134_CR71","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1016\/0002-8703(93)90128-V","volume":"125","author":"MW Gillman","year":"1993","unstructured":"Gillman MW, Kannel WB, Belanger A, D'Agostino RB. Influence of heart rate on mortality among persons with hypertension: the Framingham Study. Am Heart J. 1993;125:1148\u201354.","journal-title":"Am Heart J"},{"key":"1134_CR72","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1001\/jama.1954.02950130006002","volume":"156","author":"CS Beck","year":"1954","unstructured":"Beck CS, Leighninger DS. Operations for coronary artery disease. J Am Med Assoc. 1954;156:1226\u201333.","journal-title":"J Am Med Assoc"},{"key":"1134_CR73","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1001\/jama.1955.02960300008003","volume":"159","author":"CS Beck","year":"1955","unstructured":"Beck CS, Leighninger DS. Scientific basis for the surgical treatment of coronary artery disease. J Am Med Assoc. 1955;159:1264\u201371.","journal-title":"J Am Med Assoc"},{"key":"1134_CR74","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1745-6215-14-46","volume":"14","author":"EM Jolicoeur","year":"2013","unstructured":"Jolicoeur EM, Banai S, Henry TD, et al. A phase II, sham-controlled, doubleblinded study testing the safety and efficacy of the coronary sinus reducer in patients with refractory angina: study protocol for a randomized controlled trial. Trials. 2013;14:46.","journal-title":"Trials"},{"issue":"6","key":"1134_CR75","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1056\/NEJMoa1402556","volume":"372","author":"Stefan Verheye","year":"2015","unstructured":"\u2022\u2022 Verheye S, Jolicoeur EM, Behan MW, et al. Eficacy of a device to narrow the coronary sinus in refractory angina. N Engl J Med. 2015;372:519\u201327. This is a well-conducted, phase 2, multicenter, randomized, double-blind, sham-controlled clinical trial to test the safety and efficacy of the coronary-sinus reducing device.","journal-title":"New England Journal of Medicine"},{"issue":"1\u20132","key":"1134_CR76","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1023\/B:MCBI.0000044385.55012.8f","volume":"264","author":"Mukherjee","year":"2004","unstructured":"Mukherjee, et al. Current clinical perspectives on myocardial angiogenesis. Mol Cell Biochem. 2004;264(1\u20132):157\u201367.","journal-title":"Mol Cell Biochem"},{"key":"1134_CR77","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1038\/nrd1226","volume":"2","author":"M Simons","year":"2003","unstructured":"Simons M, Ware JA. Therapeutic angiogenesis in cardiovascular disease. Nat Rev Drug Discov. 2003;2:863\u201372.","journal-title":"Nat Rev Drug Discov"},{"key":"1134_CR78","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1161\/01.CIR.0000159345.00591.8F","volume":"111","author":"M Simons","year":"2005","unstructured":"Simons M. Angiogenesis: where do we stand now? Circulation. 2005;111:1556\u201366.","journal-title":"Circulation"},{"key":"1134_CR79","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1182\/blood-2006-08-043471","volume":"109","author":"MC Yoder","year":"2007","unstructured":"Yoder MC, Mead LE, Prater D, Krier TR, Mroueh KN, Li F, et al. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem\/progenitor cell principals. Blood. 2007;109:1801\u20139.","journal-title":"Blood"},{"key":"1134_CR80","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/j.1538-7836.2008.03214.x","volume":"7","author":"JD Pearson","year":"2009","unstructured":"Pearson JD. Endothelial progenitor cells - hype or hope? J Thromb Haemost. 2009;7:255\u201362.","journal-title":"J Thromb Haemost"},{"key":"1134_CR81","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1080\/mic.10.1.83.97","volume":"10","author":"A Helisch","year":"2003","unstructured":"Helisch A, Schaper W. Arteriogenesis: the development and growth of collateral arteries. Microcirculation. 2003;10:83\u201397.","journal-title":"Microcirculation"},{"key":"1134_CR82","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1161\/01.ATV.0000069625.11230.96","volume":"23","author":"W Schaper","year":"2003","unstructured":"Schaper W, Scholz D. Factors regulating arteriogenesis. Arterioscler Thromb Vasc Biol. 2003;23:1143.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1134_CR83","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1582-4934.2006.tb00290.x","volume":"10","author":"M Heil","year":"2006","unstructured":"Heil M, Eitenm\u00fcller I, Schmitz-Rixen T, Schaper W. Arteriogenesis versus angiogenesis: similarities and differences. J Cell Mol Med. 2006;10:45\u201355.","journal-title":"J Cell Mol Med"},{"key":"1134_CR84","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/nm0603-669","volume":"9","author":"N Ferrara","year":"2003","unstructured":"Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med. 2003;9:669\u201376.","journal-title":"Nat Med"},{"key":"1134_CR85","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/380435a0","volume":"380","author":"P Carmeliet","year":"1996","unstructured":"Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature. 1996;380:435\u20139.","journal-title":"Nature"},{"key":"1134_CR86","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/380439a0","volume":"380","author":"N Ferrara","year":"1996","unstructured":"Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea KS, et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature. 1996;380:439\u201342.","journal-title":"Nature"},{"key":"1134_CR87","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1023\/B:MCBI.0000044379.25823.03","volume":"264","author":"M Simons","year":"2004","unstructured":"Simons M. Integrative signaling in angiogenesis. Mol Cell Biochem. 2004;264:99\u2013102.","journal-title":"Mol Cell Biochem"},{"key":"1134_CR88","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1172\/JCI119877","volume":"101","author":"M Arras","year":"1998","unstructured":"Arras M, Ito WD, Scholz D, Winkler B, Schaper J, Schaper W. Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb. J Clin Invest. 1998;101:40\u201350.","journal-title":"J Clin Invest"},{"key":"1134_CR89","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.102.11.e73","volume":"102","author":"M Simons","year":"2000","unstructured":"Simons M, Bonow RO, Chronos NA, et al. Clinical trials in coronary angiogenesis: issues, problems, consensus: an expert panel summary. Circulation. 2000;102:E73.","journal-title":"Circulation"},{"key":"1134_CR90","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1161\/CIRCULATIONAHA.108.817528","volume":"120","author":"V Tchaikovski","year":"2009","unstructured":"Tchaikovski V, Olieslagers S, B\u00f6hmer FD, Waltenberger J. Diabetes mellitus activates signal transduction pathways resulting in vascular endothelial growth factor resistance of human monocytes. Circulation. 2009;120:150\u20139.","journal-title":"Circulation"},{"key":"1134_CR91","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.jacc.2005.06.008","volume":"46","author":"M Simons","year":"2005","unstructured":"Simons M. Angiogenesis, arteriogenesis, and diabetes: paradigm reassessed? J Am Coll Cardiol. 2005;46:835\u20137.","journal-title":"J Am Coll Cardiol"},{"key":"1134_CR92","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1161\/01.CIR.0000070540.80780.92","volume":"107","author":"M Hedman","year":"2003","unstructured":"Hedman M, Hartikainen J, Syv\u00e4nne M, et al. Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: phase II results of the Kuopio Angiogenesis Trial (KAT). Circulation. 2003;107:2677.","journal-title":"Circulation"},{"key":"1134_CR93","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.jacc.2004.12.068","volume":"45","author":"J Kastrup","year":"2005","unstructured":"Kastrup J, J\u00f8rgensen E, R\u00fcck A, T\u00e4gil K, Glogar D, Ruzyllo W, et al. Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris a randomized double-blind placebo-controlled study: the Euroinject one trial. J Am Coll Cardiol. 2005;45:982\u20138.","journal-title":"J Am Coll Cardiol"},{"key":"1134_CR94","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1161\/hc0802.104407","volume":"105","author":"M Simons","year":"2002","unstructured":"Simons M, Annex BH, Laham RJ, Kleiman N, Henry T, Dauerman H, et al. Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial. Circulation. 2002;105:788\u201393.","journal-title":"Circulation"},{"key":"1134_CR95","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1161\/01.CIR.100.18.1865","volume":"100","author":"RJ Laham","year":"1999","unstructured":"Laham RJ, Sellke FW, Edelman ER, Pearlman JD, Ware JA, Brown DL, et al. Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: results of a phase I randomized, double-blind, placebo-controlled trial. Circulation. 1999;100:1865\u201371.","journal-title":"Circulation"},{"key":"1134_CR96","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1161\/01.CIR.97.7.645","volume":"97","author":"B Schumacher","year":"1998","unstructured":"Schumacher B, Pecher P, von Specht BU, Stegmann T. Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease. Circulation. 1998;97:645\u201350.","journal-title":"Circulation"},{"key":"1134_CR97","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1161\/hc4201.097835","volume":"104","author":"C Seiler","year":"2001","unstructured":"Seiler C, Pohl T, Wustmann K, Hutter D, Nicolet PA, Windecker S, et al. Promotion of collateral growth by granulocyte-macrophage colony-stimulating factor in patients with coronary artery disease: a randomized, double-blind, placebo-controlled study. Circulation. 2001;104:2012\u20137.","journal-title":"Circulation"},{"key":"1134_CR98","first-page":"H1625","volume":"260","author":"EF Unger","year":"1991","unstructured":"Unger EF, Sheffield CD, Epstein SE. Heparin promotes the formation of extracardiac to coronary anastomoses in a canine model. Am J Phys. 1991;260:H1625.","journal-title":"Am J Phys"},{"key":"1134_CR99","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1161\/01.CIR.88.6.2517","volume":"88","author":"G Melandri","year":"1993","unstructured":"Melandri G, Semprini F, Cervi V, Candiotti N, Palazzini E, Branzi A, et al. Benefit of adding low molecular weight heparin to the conventional treatment of stable angina pectoris. A double-blind, randomized, placebo-controlled trial. Circulation. 1993;88:2517\u201323.","journal-title":"Circulation"},{"key":"1134_CR100","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0002-9149(99)00596-2","volume":"85","author":"HV Barron","year":"2000","unstructured":"Barron HV, Sciammarella MG, Lenihan K, Michaels AD, Botvinick EH. Effects of the repeated administration of adenosine and heparin on myocardial perfusion in patients with chronic stable angina pectoris. Am J Cardiol. 2000;85:1\u20137.","journal-title":"Am J Cardiol"},{"key":"1134_CR101","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1161\/CIRCRESAHA.108.184622","volume":"104","author":"M Drinane","year":"2009","unstructured":"Drinane M, Mollmark J, Zagorchev L, Moodie K, Sun B, Hall A, et al. The antiangiogenic activity of rPAI-1(23) inhibits vasa vasorum and growth of atherosclerotic plaque. Circ Res. 2009;104:337\u201345.","journal-title":"Circ Res"},{"key":"1134_CR102","unstructured":"As assessed on Clinicaltrials.gov on 12\/24\/2018. https:\/\/clinicaltrials.gov\/ct2\/show\/study\/NCT01566175?cond=Refractory+Angina&rank=3"},{"key":"1134_CR103","unstructured":"As assessed on Clinicaltrials.gov on 12\/24\/2018. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02710435?cond=Refractory+Angina&rank=31"},{"key":"1134_CR104","unstructured":"As assessed on Clinicaltrials.gov on 12\/24\/2018. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01214499?cond=Refractory+Angina&rank=22"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-019-1134-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11886-019-1134-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-019-1134-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,16]],"date-time":"2022-04-16T23:29:43Z","timestamp":1650151783000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11886-019-1134-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,22]]},"references-count":104,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["1134"],"URL":"https:\/\/doi.org\/10.1007\/s11886-019-1134-8","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,22]]},"assertion":[{"value":"22 April 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Amod Amritphale and Nupur Amritphale declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"46"}}